Compile Data Set for Download or QSAR

Found 2 hits of ic50 for monomerid = 50433037   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (Homo sapiens (Human))	BDBM50433037 (CHEMBL2375956 | US8633204, 311) Show SMILES COc1ncc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCC(N)=O)c1=O |r,wU:22.27,wD:19.20,(40.72,-44.52,;39.39,-43.75,;38.06,-44.52,;38.05,-46.06,;36.72,-46.82,;35.39,-46.05,;35.39,-44.51,;36.72,-43.74,;34.05,-46.8,;32.7,-46.02,;31.36,-46.8,;30.03,-46.04,;30.02,-44.5,;28.7,-46.81,;28.7,-48.35,;27.36,-49.12,;30.03,-49.12,;31.36,-48.35,;32.7,-49.13,;32.69,-50.67,;31.35,-51.43,;31.34,-52.96,;32.67,-53.74,;34.01,-52.98,;34.02,-51.44,;32.66,-55.28,;31.32,-56.04,;29.99,-55.26,;28.66,-56.03,;30,-53.73,;34.05,-48.36,;35.38,-49.13,)| Show InChI InChI=1S/C21H25N7O4/c1-11-15-7-16(12-8-24-21(31-2)25-9-12)19(30)28(18(15)27-20(23)26-11)13-3-5-14(6-4-13)32-10-17(22)29/h7-9,13-14H,3-6,10H2,1-2H3,(H2,22,29)(H2,23,26,27)/t13-,14-	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	4.11	n/a	n/a	n/a	n/a	7.4	25
Pfizer Inc. US Patent					Assay Description Compounds of the present invention were evaluated for potency against PI3-Kα using an in vitro kinase assay. PI3-Kα activity is measured in...				US Patent US8633204 (2014) BindingDB Entry DOI: 10.7270/Q2Q81BQT
					More data for this Ligand-Target Pair
RAC-alpha serine/threonine-protein kinase (Homo sapiens (Human))	BDBM50433037 (CHEMBL2375956 | US8633204, 311) Show SMILES COc1ncc(cn1)-c1cc2c(C)nc(N)nc2n([C@H]2CC[C@@H](CC2)OCC(N)=O)c1=O |r,wU:22.27,wD:19.20,(40.72,-44.52,;39.39,-43.75,;38.06,-44.52,;38.05,-46.06,;36.72,-46.82,;35.39,-46.05,;35.39,-44.51,;36.72,-43.74,;34.05,-46.8,;32.7,-46.02,;31.36,-46.8,;30.03,-46.04,;30.02,-44.5,;28.7,-46.81,;28.7,-48.35,;27.36,-49.12,;30.03,-49.12,;31.36,-48.35,;32.7,-49.13,;32.69,-50.67,;31.35,-51.43,;31.34,-52.96,;32.67,-53.74,;34.01,-52.98,;34.02,-51.44,;32.66,-55.28,;31.32,-56.04,;29.99,-55.26,;28.66,-56.03,;30,-53.73,;34.05,-48.36,;35.38,-49.13,)| Show InChI InChI=1S/C21H25N7O4/c1-11-15-7-16(12-8-24-21(31-2)25-9-12)19(30)28(18(15)27-20(23)26-11)13-3-5-14(6-4-13)32-10-17(22)29/h7-9,13-14H,3-6,10H2,1-2H3,(H2,22,29)(H2,23,26,27)/t13-,14-	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	52	n/a	n/a	n/a	n/a	n/a	n/a
Pfizer Inc. Curated by ChEMBL					Assay Description Inhibition of AKT phosphorylation at Ser 473 in human BT20 cells				Bioorg Med Chem Lett 23: 2787-92 (2013) Article DOI: 10.1016/j.bmcl.2013.02.020 BindingDB Entry DOI: 10.7270/Q2NZ890X
					More data for this Ligand-Target Pair